Dichloralphenazone

This classification denotes a sedative and hypnotic with the molecular formula C11H12N2O.2C2H3Cl3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YYX637R279, chemically known as 1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one, compound with 2,2,2-trichloroethane-1,1-diol (1:2) but generally known as dichloralphenazone, which bears US NIH Compound Identifier 10188. European Medicines Agency schedules Dichloralphenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13563MIG. World Health Organization schedules dichloralphenazone in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DICHLORALPHENAZONE remains the US FDA Preferred Term for this commodity. Dichloralphenazone bears US NLM identifiers UMLS ID C0057831 and NCI Concept Code C87204. SMILES: CC1=CC(=O)N(N1C)C2=CC=CC=C2.C(C(CL)(CL)CL)(O)O.C(C(CL)(CL)CL)(O)O.